Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution1 total trials
Phase 4Post-market surveillance
1(100.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)

Detailed Status

Recruiting1
Withdrawn1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (100.0%)

Trials by Status

recruiting133%
withdrawn133%
completed133%

Recent Activity

1 active trials
Showing 3 of 3
recruiting

Pediatric In-Hospital Cardiac Arrest International Registry (PACHIN)

NCT04675918
withdrawnphase_4

Impact if Desflurane Preconditioning on the Content of the Phospho-GSK-3b in the Rat's Neurons in the Model of I/R

NCT04287842
completed

Histones and Free-plasma DNA After Cardiac Arrest

NCT02733146

Clinical Trials (3)

Showing 3 of 3 trials
NCT04675918

Pediatric In-Hospital Cardiac Arrest International Registry (PACHIN)

Recruiting
NCT04287842Phase 4

Impact if Desflurane Preconditioning on the Content of the Phospho-GSK-3b in the Rat's Neurons in the Model of I/R

Withdrawn
NCT02733146

Histones and Free-plasma DNA After Cardiac Arrest

Completed

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3